Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

GEN
Gen Digital Inc. Common Stock
stock NASDAQ

Market Open
Dec 16, 2025 9:57:14 AM EST
27.64USD+0.491%(+0.14)205,158
27.63Bid   27.65Ask   0.02Spread
Pre-market
Dec 16, 2025 8:46:30 AM EST
27.50USD0.000%(0.00)100
After-hours
Dec 15, 2025 4:06:30 PM EST
27.56USD+0.236%(+0.06)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsDividendsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 25, 2022
06:30AM EST  Genmab Announces Net Sales of DARZALEX (daratumumab)   GlobeNewswire Inc
Jan 4, 2022
09:00AM EST  Genmab and Synaffix Enter into License Agreement for ADC Technology   GlobeNewswire Inc
Nov 10, 2021
11:01AM EST  November 10, 2021; Copenhagen, Denmark;Interim Report for the First Nine Months Ended September 30, 2021   GlobeNewswire Inc
Oct 19, 2021
06:30AM EDT  Genmab Announces Net Sales of DARZALEX (daratumumab)   GlobeNewswire Inc
Sep 21, 2021
02:23PM EDT  Capital Increase in Genmab as a Result of Employee Warrant Exercise   GlobeNewswire Inc
Sep 20, 2021
05:00PM EDT  -- TIVDAK is a First-in-Class Antibody-Drug Conjugate Directed to Tissue Factor, a Protein Expressedon Cervical CancerCells -- New Monotherapy Approved for Use in a Cancer with Limited Treatment Options   GlobeNewswire Inc
Aug 11, 2021
11:02AM EDT  August 11, 2021; Copenhagen, Denmark;Interim Report for the First Half of 2021   GlobeNewswire Inc
Jul 21, 2021
12:58PM EDT  Major Shareholder Announcement   GlobeNewswire Inc
06:32AM EDT  Genmab Announces Net Sales of DARZALEX (daratumumab)   GlobeNewswire Inc
Jun 22, 2021
10:13AM EDT  Genmab Announces that Janssen has Received European Marketing   GlobeNewswire Inc
May 21, 2021
09:08AM EDT  Genmab Announces that Janssen has Received Positive CHMP Opinion   GlobeNewswire Inc
May 5, 2021
11:02AM EDT  Genmab Announces Financial Results for the First Quarter of 2021   GlobeNewswire Inc
Apr 20, 2021
06:35AM EDT  Genmab Announces Net Sales of DARZALEX (daratumumab)   GlobeNewswire Inc
Apr 9, 2021
04:00PM EDT  Genmab and Seagen Announce U.S. FDA Filing Acceptance for Priority   GlobeNewswire Inc
Mar 30, 2021
01:21AM EDT  Genmab Announces European Marketing Authorization for   GlobeNewswire Inc
Mar 23, 2021
08:30AM EDT  Highly Regarded Turnaround Specialist, Harry Wilson, Appointed CEO   GlobeNewswire Inc
Mar 3, 2021
12:52PM EST  Genesis HealthCare Shares Are Trading Lower After Debt Restructuring Deal, Voluntary Delisting From NYSE   Benzinga
10:36AM EST  Genesis HealthCare Earlier Announced It Will Voluntarily Delist Common Stock From New York Stock Exchange   Benzinga
09:03AM EST  Genesis Healthcare Inc. (GEN) announced a strategic restructuring plan to strengthen its liquidity position and capital structure.   RTTNews
08:51AM EST  Genesis Healthcare Announces Three-part Strategic Restructuring Plan   RTTNews
08:31AM EST  Genesis HealthCare Announces Strategic Restructuring Steps To Reduce Debt By ~$256M, Includes Immediate $50M Capital Investment   Benzinga
08:30AM EST  Genesis HealthCare Announces Strategic Restructuring Steps to   GlobeNewswire Inc
Mar 2, 2021
06:39PM EST  Welltower and ProMedica Announce Strategic Transactions to Enhance Partnership   PR Newswire
Feb 23, 2021
11:06AM EST  Genmab announces initiation of share buy-back program   GlobeNewswire Inc
11:01AM EST  Genmab Publishes 2020 Annual Report   GlobeNewswire Inc
Feb 22, 2021
08:01AM EST  Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created   GlobeNewswire Inc
Feb 10, 2021
04:05PM EST  Genmab and Seagen Submit Tisotumab Vedotin Biologics License   GlobeNewswire Inc
Feb 2, 2021
06:37PM EST  To date, 84% of skilled nursing residents and 61% of skilled nursing staff have been vaccinated; Staff acceptance rates far exceed national average as reported by CDC   GlobeNewswire Inc
Jan 29, 2021
12:10PM EST  CHMP Issues Positive Opinion Recommending Ofatumumab in Relapsing   GlobeNewswire Inc
Jan 26, 2021
06:45AM EST  Genmab Announces 2020 Net Sales of DARZALEX (daratumumab)   GlobeNewswire Inc
Jan 25, 2021
10:03AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 25, 2021   Benzinga
06:12AM EST  Credit Suisse Downgrades Genesis Healthcare to Underperform, Announces $0.57 Price Target   Benzinga
Jan 18, 2021
10:10AM EST  LTC ACO and Third Eye Health Offer Virtual Care Network to   GlobeNewswire Inc
Jan 15, 2021
02:18PM EST  Genmab Announces that Janssen has been Granted U.S. FDA Approval   GlobeNewswire Inc
Jan 13, 2021
09:20AM EST  Genmab Achieves USD 40 Million Milestone in Collaboration with AbbVie   GlobeNewswire Inc
Jan 5, 2021
08:34AM EST  Genesis HealthCare Announces Retirement Of CEO And Director George V. Hager, Jr.; Chairman Robert H. Fish Appointed CEO   Benzinga
08:30AM EST  George V. Hager, Jr.Retires as CEO and DirectorBoard of Directors Appoints Current Chairman, Robert H. Fish as New CEO   GlobeNewswire Inc
Jan 4, 2021
02:00PM EST  Genmab Announces Phase 3 Trial of Tisotumab Vedotin in Recurrent   GlobeNewswire Inc
Dec 23, 2020
12:59PM EST  Franklin Woods Center Among the First Long-Term Care Facilities in   GlobeNewswire Inc
Dec 18, 2020
03:47PM EST  Residents and healthcare workers at The Reservoir Center, a Genesis HealthCare- (NYSE:GEN) (Genesis or the Company) affiliated nursing home, became the first long-term care facility in Connecticut and among the first in the U.S. to receive the COVID-19 vaccination today. Genesis HealthCare is one of the nations largest providers of post-acute care.   GlobeNewswire Inc
Dec 17, 2020
01:27PM EST  Silver Lake Center, Affiliated with Genesis HealthCare, Among the   GlobeNewswire Inc
Nov 24, 2020
10:40AM EST  Genmab Announces Enapotamab Vedotin Update   GlobeNewswire Inc
Nov 16, 2020
04:01PM EST  LTC ACO Contracts with Eventus WholeHealth   GlobeNewswire Inc
Nov 11, 2020
08:31AM EST  Credit Suisse Maintains Neutral on Genesis Healthcare, Lowers Price Target to $0.57   Benzinga
Nov 9, 2020
07:15AM EST  Recap: Genesis Healthcare Q3 Earnings   Benzinga
06:17AM EST  Genesis Healthcare Reports The COVID-19 Pandemic Reduced Earnings Nearly $60M In Q3   Benzinga
06:14AM EST  Genesis Healthcare Q3 EPS $(0.55) Down From $0.26 YoY, Sales $938.65M Down From $1.12B YoY   Benzinga
06:00AM EST  Genesis Healthcare, Inc. (Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care providers in the United States, today announced operating results for the third quarter ended September 30, 2020 and provided an update regarding the impact of the 2019 novel coronavirus (COVID-19) pandemic on its business.   GlobeNewswire Inc
04:13AM EST  Earnings Scheduled For November 9, 2020   Benzinga
Nov 6, 2020
08:45AM EST  Genesis Healthcare to Release Third Quarter 2020 Results and   GlobeNewswire Inc
Nov 4, 2020
11:04AM EST  November 4, 2020; Copenhagen, Denmark; Interim Report for the First Nine Months Ended September 30, 2020   GlobeNewswire Inc
Oct 21, 2020
04:49PM EDT  Genmab Announces IFM, HOVON and Janssen Achieve Positive Topline   GlobeNewswire Inc
Oct 15, 2020
04:30PM EDT  10 Stocks Moving In Tuesday's After-Hours Session   Benzinga
Oct 14, 2020
08:42AM EDT  Looking Into Genesis Healthcare's Return On Capital Employed   Benzinga
Oct 13, 2020
05:21PM EDT  10 Stocks Moving In Tuesday's After-Hours Session   Benzinga
04:04PM EDT  Genesis HealthCare Subsidiary LTC ACO Receives Positive Reconciliation And Settlement Under The Medicare Shared Savings Program (MSSP)   Benzinga
04:03PM EDT  LTC ACO, the first long-term care sponsored Accountable Care Organization (ACO) in the United States and a subsidiary of Genesis HealthCare (Genesis) (NYSE:GEN), recently received a positive reconciliation and settlement under the Medicare Shared Savings Program (MSSP) for the 2019 performance year and as a result, generated shared savings for the second consecutive year.   GlobeNewswire Inc
06:42AM EDT  Genmab Announces Net Sales of DARZALEX (daratumumab)   GlobeNewswire Inc
Oct 5, 2020
09:45AM EDT  5 Value Stocks To Watch In The Healthcare Sector   Benzinga
Sep 22, 2020
05:04PM EDT  Genmab Commences Binding Arbitration of Two Matters Under License   GlobeNewswire Inc
Sep 21, 2020
10:20AM EDT  Media ReleaseCOPENHAGEN, Denmark and BOTHELL, Wash., 21 September 2020   GlobeNewswire Inc
Aug 31, 2020
08:41AM EDT  Overview Of Value Stocks In The Healthcare Sector   Benzinga
Aug 20, 2020
04:41PM EDT  Genmab Announces Janssen Granted U.S. FDA Approval for   GlobeNewswire Inc
04:07PM EDT  Genmab Announces Plan to Transition Arzerra   GlobeNewswire Inc
01:34PM EDT  U.S. FDA Approves Kesimpta (ofatumumab) in Relapsing   GlobeNewswire Inc
Aug 12, 2020
11:24AM EDT  Genmab Announces Financial Results for the First Half of 2020   GlobeNewswire Inc
Aug 11, 2020
10:01AM EDT  Healthcare Services Group Shares Fall To Session Low, Now Down 3.6%, As Hearing Credit Suisse Downgrades To Neutral, Sees Exposure To Genesis Healthcare As 'Going-Concern Risk'   Benzinga
Aug 10, 2020
04:59PM EDT  Genesis Healthcare Q2 EPS $(0.20) Misses $(0.03) Estimate, Sales $956.26M Miss $1.12B Estimate   Benzinga
04:10AM EDT  Earnings Scheduled For August 10, 2020   Benzinga
Aug 5, 2020
04:01PM EDT  Genesis Healthcare to Release Second Quarter 2020 Results and   GlobeNewswire Inc
Aug 3, 2020
01:15PM EDT  5 Value Stocks In The Healthcare Sector   Benzinga
Jul 31, 2020
03:38PM EDT  Genmab Announces European Myeloma Network and Janssen Achieve   GlobeNewswire Inc
Jul 27, 2020
01:54AM EDT  5 Value Stocks In The Healthcare Sector   Benzinga
Jul 23, 2020
04:21PM EDT  As part of an effort to reduce avoidable hospital readmissions along with gaps in care coordination both within and across settings, and to improve outcomes for patients, the American Heart Association has awarded the first Post-Acute Care Heart Failure Center Certification to eight Genesis HealthCare (Genesis) skilled nursing facilities.   GlobeNewswire Inc
Jul 20, 2020
11:58AM EDT  Major Shareholder Announcement   GlobeNewswire Inc
Jul 16, 2020
06:44AM EDT  Genmab Announces Net Sales of DARZALEX for the Second   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC